Prescribed medications, though generally safe when taken as directed, can pose risks if taken in higher than prescribed doses or combined with other substances. This edition of Clinical Insight will highlight a few prescription medications that have been known to be misused.
The opioid epidemic in the United States has evolved over the years, with the substances and adulterants involved changing over time. Fentanyl has increasingly been found in the drug supply, contributing to a dramatic rise in overdose deaths. More recently, the veterinary drug Xylazine has emerged as an additive to not only fentanyl but also other drugs of misuse, resulting in a growing number of overdose deaths nationwide. Given that many people are not aware that the drugs they are using contain Xylazine, these mixtures are particularly concerning. This edition of Clinical Insight explores what Xylazine is, its effects, and the challenges it presents within the illicit drug supply.
Marijuana is the most commonly abused illicit substance in the United States. Because THC can come from a variety of sources and test results may be influenced by multiple factors, this issue of Clinical Insight reviews key concepts to consider.
Creatinine adjustment is essential for accurate interpretation of drug elimination in many cases. Learn from our clinical services team about how elimination monitoring can help you to better understand your patient’s results.
We are proud to announce that we have been Certified™ by Great Place To Work® in 2026!
90% of our employees affirmed that it’s a great place to work, compared to 57% of employees at a typical U.S. company
2025 marks the tenth consecutive year Dominion Diagnostics has received a Worksite Health Award in the Exemplary or Superior Category from BlueCross BlueShield!
We are proud to announce that we have been Certified™ by Great Place To Work® in 2025!
92% of our employees affirmed that it’s a great place to work, compared to 57% of employees at a typical U.S. company
Did you know that Dominion Diagnostics offers drug monitoring solutions specifically designed for telehealth programs? We provide both urine and oral fluid testing options, making it easier than ever for your patients to receive care from the comfort of their own homes.
2024 marks the ninth consecutive year Dominion Diagnostics has received a Worksite Health Award in the Exemplary or Superior Category from BlueCross BlueShield in their Worksite Health Awards!
We are proud to announce that we have been Certified™ by Great Place To Work® in 2024!
90% of our employees affirmed that it’s a great place to work, compared to 57% of employees at a typical U.S. company
Automate your urine drug testing randomization process and save valuable staff time with our Randomization solution available through Dominion Connect™
2023 marks the eighth consecutive year Dominion Diagnostics has received a Worksite Health Award in the Exemplary or Superior Category from BlueCross BlueShield in their Worksite Health Awards!
Dominion Diagnostics was recently named as one of the 2023 Best Places to Work in Rhode Island. This marks the fourth year in a row, and seventh time overall, that Dominion has been recognized with this award.
Dominion Diagnostics was recently named as one of the 2022 Best Places to Work in Rhode Island. This marks the third year in a row, and sixth time overall, that Dominion has been recognized with this award.
Dominion Diagnostics was recognized with an Exemplary Worksite Health Award from Blue Cross & Blue Shield of Rhode Island (BCBSRI) and the Greater Providence Chamber of Commerce (the Chamber) for effective programs encouraging employee health and well-being in a meaningful way.
Dominion’s Research & Development team recently participated in the international conference for mass spectrometry, American Society for Mass Spectrometry or ASMS. Ana Grenier, Ph.D. was selected to present as one of the speakers where she presented a talk called “Strategies to Identify and Mitigate Interferences in Urine Drug Testing LC MS/MS Methods.”
Dominion Diagnostics is a well-respected, trusted healthcare company with over two decades of experience and expertise delivering patient-centered drug monitoring solutions, improved treatment outcomes and actionable clinical information to inform care.
A new scholarship advancing addiction recovery in the state of Vermont has been established to support the Vermont Foundation of Recovery (VFOR) by Dominion Diagnostics
Today, Rhode Island-based medical laboratory Dominion Diagnostics joined thousands of other organizations and individuals across the globe to commemorate International Overdose Awareness Day during an event held for its employees. The day itself demands urgent action and is aimed to raise awareness of overdose and reduce the stigma of a drug-related death.
877.734.9600
401.667.5688